As a result, downregulation of AKT in bladder cancer cells, which have already spread to the bone, promotes mesenchymal-epithelial transition (MET) and, thus, growth of epithelial-like cancer cells in the bone marrow [164]. The gene discussed is AKT1; the disease is urinary bladder cancer.